{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:56:59Z","timestamp":1785855419403,"version":"3.56.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Iatrogenic lymphoproliferative disorder (LPD) can develop in patients treated with immunosuppressive drugs for autoimmune or other inflammatory diseases. Here, we report a case of lymphomatoid granulomatosis of the skin that occurred as a methotrexate (MTX)-associated LPD. We also review the relevant literature. A 73-year-old woman presented to our department with an approximately 10-year history of MTX therapy for rheumatoid arthritis. Three months earlier, she noticed a small nodule in her right upper arm. It gradually enlarged, and the center began to decay. Grossly, the lesion was 40 \u00d7 40 mm in size with ulceration, and the surrounding skin presented dark red erythema. A biopsy specimen was taken for definitive diagnosis. Histologically, infiltrating growth of medium-to-large atypical lymphocytes was observed underneath the ulceration and was accompanied by small reactive lymphocytes. The atypical lymphocytes demonstrated a tendency to infiltrate the vessels, which showed an angiocentric pattern. Immunohistochemistry revealed that the atypical lymphoid cells were positive for CD79a, CD20, and CD30. In addition, in situ hybridization for Epstein\u2013Barr virus (EBV) revealed expression of EBV-encoded small RNAs. The patient was diagnosed with MTX-associated LPD (lymphomatoid granulomatosis), owing to her history of MTX treatment, the expression of the atypical lymphocytes for B-cell markers and EBV-encoded small RNA, and the angiocentric infiltrating pattern. The lesion reportedly disappeared after withdrawal of MTX.<\/jats:p>","DOI":"10.1097\/dad.0000000000001301","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T17:01:50Z","timestamp":1557162110000},"page":"448-452","source":"Crossref","is-referenced-by-count":8,"title":["A Case of Methotrexate-Associated Lymphoproliferative Disorder (Lymphomatoid Granulomatosis) of the Skin"],"prefix":"10.1097","volume":"41","author":[{"given":"Haruto","family":"Nishida","sequence":"first","affiliation":[{"name":"Diagnostic Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Oyama","sequence":"additional","affiliation":[{"name":"Diagnostic Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kusaba","sequence":"additional","affiliation":[{"name":"Diagnostic Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Kadowaki","sequence":"additional","affiliation":[{"name":"Diagnostic Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoki","family":"Arakane","sequence":"additional","affiliation":[{"name":"Diagnostic Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Yokoyama","sequence":"additional","affiliation":[{"name":"Diagnostic Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Hatano","sequence":"additional","affiliation":[{"name":"Dermatology, Faculty of Medicine, Oita University, Oita, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Daa","sequence":"additional","affiliation":[{"name":"Diagnostic Pathology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R4-20230908","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archderm.1981.01650040012011","article-title":"Cutaneous manifestations of lymphomatoid granulomatosis. Report of 44 cases and a review of the literature","volume":"117","author":"James","year":"1981","journal-title":"Arch Dermatol."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archderm.1996.03890360054010","article-title":"Lymphomatoid granulomatosis of the skin and lung: an angiocentric T-cell-rich B-cell lymphoproliferative disorder","volume":"132","author":"McNiff","year":"1996","journal-title":"Arch Dermatol."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200109000-00001","article-title":"Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features","volume":"25","author":"Beaty","year":"2001","journal-title":"Am J Surg Pathol."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/03009740600902403","article-title":"Methotrexate-related lymphomatoid granulomatosis: a case report of spontaneous regression of large tumours in multiple organs after cessation of methotrexate therapy in rheumatoid arthritis","volume":"36","author":"Shimada","year":"2007","journal-title":"Scand J Rheumatol."},{"key":"R8-20230908","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00277-013-1741-1","article-title":"Reversible iatrogenic, MTX-associated EBV-driven lymphoproliferation with histopathological features of a lymphomatoid granulomatosis in a patient with rheumatoid arthritis","volume":"92","author":"Kobayashi","year":"2013","journal-title":"Ann Hematol."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s10067-006-0480-2","article-title":"Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis","volume":"26","author":"Kameda","year":"2007","journal-title":"Clin Rheumatol."},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1159\/000218356","article-title":"Lymphomatoid granulomatosis in a patient with rheumatoid arthritis receiving methotrexate: successful treatment with the anti-CD20 antibody mabthera","volume":"32","author":"Schalk","year":"2009","journal-title":"Onkologie."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2169\/internalmedicine.53.2593","article-title":"Grade 3 lymphomatoid granulomatosis in a patient receiving methotrexate therapy for rheumatoid arthritis","volume":"53","author":"Oiwa","year":"2014","journal-title":"Intern Med."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1200\/JCO.2012.46.2770","article-title":"Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis","volume":"31","author":"Ochi","year":"2013","journal-title":"J Clin Oncol."},{"key":"R13-20230908","first-page":"119","article-title":"Fatal pulmonary lymphomatoid granulomatosis in a patient taking methotrexate for rheumatoid arthritis","volume":"80","author":"Blanchart","year":"2014","journal-title":"Minerva Anestesiol."},{"key":"R14-20230908","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1186\/2193-1801-3-751","article-title":"Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis","volume":"3","author":"Barakat","year":"2014","journal-title":"Springerplus."},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2169\/internalmedicine.54.2399","article-title":"Primary cerebral lymphomatoid granulomatosis progressing to methotrexate-associated lymphoproliferative disease under immunosuppressive therapy","volume":"54","author":"Tanaka","year":"2015","journal-title":"Intern Med."},{"key":"R16-20230908","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1634\/theoncologist.2008-0036","article-title":"EBV-associated lymphoproliferative disorders: classification and treatment","volume":"13","author":"Carbone","year":"2008","journal-title":"Oncologist."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1183\/09031936.98.12010102","article-title":"Lymphomatoid granulomatosis\u2014a report on four cases: evidence for B phenotype of the tumoral cells","volume":"12","author":"Tani\u00e8re","year":"1998","journal-title":"Eur Respir J."},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3899\/jrheum.130270","article-title":"A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders","volume":"41","author":"Yamakawa","year":"2014","journal-title":"J Rheumatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000372-201906000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:37:53Z","timestamp":1785854273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000372-201906000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000001301","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}